Haleon to invest $54 mln in US R&D centre to ... invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new product innovations.

Robitussin maker Haleon has agreed to pay $4.5 million to resolve claims it advertised the product as “non-drowsy” despite containing an ingredient that could cause sleepiness, TopClassAction ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Robitussin’s manufacturer, Haleon, denied any wrongdoing and agreed to the settlement to avoid legal expenses, according to the settlement website. It did not respond to requests for comment by ...

May 1 (Reuters) - Haleon (HLN.L), opens new tab on Thursday raised its medium-term target for profit growth from 2026, banking on strength in key markets and costs cuts within its supply chain ...

Haleon is one of the largest consumer healthcare companies in the world. Over the last few years, Haleon has achieved a more rationalized operation by divesting multiple non-strategic brands ...

GSK, its consumer health spin-off Haleon, and Sanofi could be on the hook for billions of dollars in potential damages over Zantac, a gastrointestinal drug pulled from the market in 2020 after it ...

(RTTNews) - Haleon Plc (HLN), a British consumer healthcare company, reported Wednesday weak revenues in its first quarter on a reported basis, while organic revenue grew 3.5 percent with growth ...

In addition to this collaboration agreement, Brightseed will work with Haleon to make Forager directly accessible to Haleon’s scientists, enabling efficient natural bioactive discovery by ...

Most readers would already be aware that Haleon's (LON:HLN) stock increased significantly by 13% over the past month. However, we decided to pay attention to the company's fundamentals which don't ...